Floatz logo

197 assets in Follicular Lymphoma

Therapeutic assets addressing Follicular Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Sctb35
Follicular Lymphoma
Sinocelltech Ltd.P3B (57)
Talikabtagene Autoleucel
Follicular Lymphoma
Health Institutes of TurkeyP2/3B (57)
Tocilizumab
Follicular Lymphoma
Hoffmann-La RocheP3B (57)
Atezolizumab
Follicular Lymphoma
Hoffmann-La RocheP2B (56)
Duvelisib
Follicular Lymphoma
Ruijin HospitalP3B (56)
mk-1045
Follicular Lymphoma
Merck Sharp & Dohme LLCP2/3CCC (54)
Ublituximab
Follicular Lymphoma
City of Hope Medical CenterP2/3CCC (54)
Zandelisib
Follicular Lymphoma
Jacob Soumerai, MDP3CCC (54)
Conjugated Pneumococcal Vaccine
Follicular Lymphoma
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
Ontorpacept
Follicular Lymphoma
Mayo ClinicP2CCC (53)
Sirolimus
Follicular Lymphoma
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Treosulfan
Follicular Lymphoma
Fred Hutchinson Cancer CenterP2CCC (53)
Zuberitamab
Follicular Lymphoma
Sun Yat-sen UniversityP2CCC (53)
Anti-Cd19/Cd22 Car-T Cells
Follicular Lymphoma
First Affiliated Hospital Xi'an Jiaotong UniversityP1/2CCC (52)
Cart-19 Cells
Follicular Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP3CCC (52)
Idelalisib
Follicular Lymphoma
ADC Therapeutics S.A.P3CCC (52)
Nemtabrutinib
Follicular Lymphoma
Merck Sharp & Dohme LLCP2CCC (52)
Pirtobrutinib
Follicular Lymphoma
University of WashingtonP2CCC (52)
Retifanlimab
Follicular Lymphoma
University of Alabama at BirminghamP1/2CCC (52)
tqb2825
Follicular Lymphoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.P3CCC (52)
Zilovertamab Vedotin
Follicular Lymphoma
Merck Sharp & Dohme LLCP2CCC (52)
Allopurinol
Follicular Lymphoma
Masonic Cancer Center, University of MinnesotaP2CCC (51)
Thiotepa
Follicular Lymphoma
Fred Hutchinson Cancer CenterP2CCC (51)
Belinostat
Follicular Lymphoma
National Cancer Institute (NCI)P1CCC (50)
Diphenhydramine
Follicular Lymphoma
M.D. Anderson Cancer CenterP2CCC (50)
Umbralisib
Follicular Lymphoma
City of Hope Medical CenterP2/3CCC (50)
[18F]F-RESCA-R8B4
Follicular Lymphoma
RenJi HospitalP2CCC (48)
[18F]F-RESCA-RCCB6
Follicular Lymphoma
RenJi HospitalP2CCC (48)
[18F]F-RESCA-RD06
Follicular Lymphoma
RenJi HospitalP2CCC (48)
[68ga]ga-nota-r8b4
Follicular Lymphoma
RenJi HospitalP2CCC (48)
[68ga]ga-nota-rd06
Follicular Lymphoma
RenJi HospitalP2CCC (48)
Abexinostat
Follicular Lymphoma
Xynomic Pharmaceuticals, Inc.P2CCC (48)
Autologous Cd4+ And Cd8+ T Cells, Enriched From Peripheral Blood Mononuclear Cells (Pbmcs) Transduced With A Nonreplicative Self-Inactivating (Sin) Lentiviral Vector Encoding A Chimeric Antigen Receptor (Car) Consisting Of The Human Cd19-Specific Scfv, An Lgg4 Hinge Region, Cd28 Transmembrane Domain, Cd137 (4-1Bb) Co-Stimulatory Domain And Cd3 Zeta Signalling Domain, Under The Control Of A Hybrid Elongation Factor 1 Alpha (Ef1.Alpha.) And Human T Cell Leukemia Virus Type 1(Htlv-1) Regulatory Element Promoter And Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (Wpre). The Vector Genome Also Encodes A Truncated Human Epidermal Growth Factor Receptor (Egfrt) That Is Co-Expressed With The Car And Cleaved From It By The T2A Self-Cleaving Peptide. The Vector Genome Also Contains A Splice Donor, A Fragment Of Gag, A Rev Response Element (Rre), A Mutated Central Polypurine Tract (Cppt), And A Splice Acceptor
Follicular Lymphoma
Sun Yat-sen UniversityP2CCC (48)
Baff-R Car-T
Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP1/2CCC (48)
cd19 specific chimeric antigen receptor t cell
Follicular Lymphoma
Pell Bio-Med Technology Co., Ltd.P1/2CCC (48)
Copanlisib
Follicular Lymphoma
Columbia UniversityP2CCC (48)
Emapalumab
Follicular Lymphoma
Marcela V. Maus, M.D.,Ph.D.P2CCC (48)
Epsametostat
Follicular Lymphoma
Haihe Biopharma Co., Ltd.P1/2CCC (48)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)
Follicular Lymphoma
Reid Merryman, MDP2CCC (48)
Interleukin 18 (Recombinant Human Mutein Clone St-067)
Follicular Lymphoma
Fred Hutchinson Cancer CenterP1/2CCC (48)
Lentivirus Vector Ccr5 Shrna
Follicular Lymphoma
AIDS Malignancy ConsortiumP1/2CCC (48)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
Follicular Lymphoma
AIDS Malignancy ConsortiumP1/2CCC (48)
Linperlisib
Follicular Lymphoma
The First Affiliated Hospital of Xiamen UniversityP2CCC (48)
mb-106
Follicular Lymphoma
Mustang BioP1/2CCC (48)
mdx2003
Follicular Lymphoma
ModeX Therapeutics, An OPKO Health CompanyP1/2CCC (48)
Orelabrutinib
Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2CCC (48)
Pralatrexate
Follicular Lymphoma
City of Hope Medical CenterP1/2CCC (48)
Selinexor
Follicular Lymphoma
Barbara Ann Karmanos Cancer InstituteP1/2CCC (48)
shr2554
Follicular Lymphoma
Jiangsu HengRui Medicine Co., Ltd.P2CCC (48)
tc011
Follicular Lymphoma
TICAROS Co., Ltd.P1/2CCC (48)
Showing 51 to 100 of 197 assets
PreviousPage 2 of 4Next